Загрузка...
Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease
BACKGROUND: Indacaterol, a once-daily, long-acting β(2)-agonist, may improve not only respiratory function, dyspnea symptoms, and quality of life, but also physical activity for patients with chronic obstructive pulmonary disease (COPD). This study aimed to evaluate the effect of 12-week indacaterol...
Сохранить в:
| Опубликовано в: : | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354394/ https://ncbi.nlm.nih.gov/pubmed/25767381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S76836 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|